Structure-based design of novel naproxen derivatives targeting monomeric nucleoprotein of Influenza A virus

References

• Arranz, R., Coloma, R., Chichon, F. J., Conesa, J. J., Carrascosa, J. L., Valpuesta, J. M., … Martin-Benito, J. (2012). The structure of native influenza virion ribonucleoproteins. Science, 338, 1634–1637.10.1126/science.1228172
   PubMed Web of Science ®Google Scholar
• Butler, J., Hooper, K. A., Petrie, S., Lee, R., & Maurer-Stroh, S. (2014). Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses. PLoS Pathogens, 10, e1004065.10.1371/journal.ppat.1004065
   Web of Science ®Google Scholar
• Chan, W. H., Ng, A. K., Robb, N. C., Lam, M. K., Chan, P. K., Au, S. W., … Shaw, P. C. (2010). Functional analysis of the influenza virus H5N1 nucleoprotein tail loop reveals amino acids that are crucial for oligomerization and ribonucleoprotein activities. Journal of Virology, 84, 7337–7345.10.1128/JVI.02474-09
   PubMed Web of Science ®Google Scholar
• Chaurasiya, K. R., McCauley, M. J., Wang, W., Qualley, D. F., Wu, T., Kitamura, S., … Williams, M. C. (2014). Oligomerization transforms human APOBEC3G from an efficient enzyme to a slowly dissociating nucleic acid-binding protein. Nature Chemistry, 6, 28–33.
   PubMed Web of Science ®Google Scholar
• Chenavas, S., Crépin, T., Delmas, B., Ruigrok, R. W., & Slama-Schwok, A. (2013). Influenza virus nucleoprotein: Structure, RNA binding, oligomerization and antiviral drug target. Future Microbiology, 8, 1537–1545.10.2217/fmb.13.128
   PubMed Web of Science ®Google Scholar
• Chenavas, S., Estrozi, L. F., Slama-Schwok, A., Delmas, B., Di Primo, C., Baudin, F., … Ruigrok, R. W. (2013). Monomeric nucleoprotein of influenza A virus. PLoS Pathogens, 9, e1003275.10.1371/journal.ppat.1003275
   PubMed Web of Science ®Google Scholar
• Courchay, F. C., Sworen, J. C., Ghiviriga, I., Abboud, K. A., & Wagener, K. B. (2006). Understanding structural isomerization during ruthenium-catalyzed olefin metathesis: A deuterium labeling study. Organometallics, 25, 6074–6086.10.1021/om0509894
   Web of Science ®Google Scholar
• Darden, T., York, D. M., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98, 10089–10092.10.1063/1.464397
   Web of Science ®Google Scholar
• Das, K., Aramini, J. M., Ma, L. C., Krug, R. M., & Arnold, E. (2010). Structures of influenza A proteins and insights into antiviral drug targets. Nature Structural & Molecular Biology, 17, 530–538.
   PubMed Web of Science ®Google Scholar
• Elton, D., Medcalf, E., Bishop, K., & Digard, P. (1999). Oligomerization of the influenza virus nucleoprotein: Identification of positive and negative sequence elements. Virology, 260, 190–200.10.1006/viro.1999.9818
   PubMed Web of Science ®Google Scholar
• Harvey, R. G., Dai, Q., Ran, C., & Penning, T. M. (2004). Synthesis of the o-Quinones and other oxidized metabolites of polycyclic aromatic hydrocarbons implicated in carcinogenesis. The Journal of Organic Chemistry, 69, 2024–2032.10.1021/jo030348n
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, 79, 926–935.10.1063/1.445869
   Web of Science ®Google Scholar
• Krug, R. M., & Aramini, J. M. (2009). Emerging antiviral targets for influenza A virus. Trends in Pharmacological Sciences, 30, 269–277.10.1016/j.tips.2009.03.002
   PubMed Web of Science ®Google Scholar
• Lejal, N., Tarus, B., Bouguyon, E., Chenavas, S., Bertho, N., Delmas, B., … Slama-Schwok, A. (2013). Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus. Antimicrobial Agents and Chemotherapy, 57, 2231–2242.10.1128/AAC.02335-12
   PubMed Web of Science ®Google Scholar
• Longhi, S., Receveur-Brechot, V., Karlin, D., Johansson, K., Darbon, H., Bhella, D., … Canard, B. (2003). The C-terminal domain of the measles virus nucleoprotein is intrinsically disordered and folds upon binding to the C-terminal moiety of the phosphoprotein. Journal of Biological Chemistry, 278, 18638–18648.10.1074/jbc.M300518200
   PubMed Web of Science ®Google Scholar
• Lopez-Martinez, R., Ramirez-Salinas, G. L., Correa-Basurto, J., & Barron, B. L. (2013). Inhibition of influenza A virus infection in vitro by peptides designed in silico. PLoS ONE, 8, e76876.10.1371/journal.pone.0076876
   Google Scholar
• MacKerell, A. D., Jr, Banavali, N., & Foloppe, N. (2000). Development and current status of the CHARMM force field for nucleic acids. Biopolymers, 56, 257–265.10.1002/(ISSN)1097-0282
   PubMed Web of Science ®Google Scholar
• Matsunaga, N., Kaku, T., Ojida, A., Tanaka, T., Hara, T., Yamaoka, M., … Tasaka, A. (2004). C(17,20)-lyase inhibitors. Part 2: Design, synthesis and structure-activity relationships of (2-naphthylmethyl)-1H-imidazoles as novel C(17,20)-lyase inhibitors. Bioorganic & Medicinal Chemistry, 12, 4313–4336.
   PubMed Web of Science ®Google Scholar
• Mavrakis, M., Méhouas, S., Réal, E., Iseni, F., Blondel, D., Tordo, N., & Ruigrok, R. W. (2006). Rabies virus chaperone: Identification of the phosphoprotein peptide that keeps nucleoprotein soluble and free from non-specific RNA. Virology, 349, 422–429.10.1016/j.virol.2006.01.030
   PubMed Web of Science ®Google Scholar
• Mena, I., Jambrina, E., Albo, C., Perales, B., Ortin, J., Arrese, M., … Portela, A. (1999). Mutational analysis of influenza A virus nucleoprotein: Identification of mutations that affect RNA replication. Journal of Virology, 73, 1186–1194.
   PubMed Web of Science ®Google Scholar
• Moeller, A., Kirchdoerfer, R. N., Potter, C. S., Carragher, B., & Wilson, I. A. (2012). Organization of the influenza virus replication machinery. Science, 338, 1631–1634.10.1126/science.1227270
   PubMed Web of Science ®Google Scholar
• Ng, A. K., Wang, J. H., & Shaw, P. C. (2009). Structure and sequence analysis of influenza A virus nucleoprotein. Science in China Series C: Life Sciences, 52, 439–449.10.1007/s11427-009-0064-x
   PubMedGoogle Scholar
• Ng, A. K., Zhang, H., Tan, K., Li, Z., Liu, J. H., Chan, P. K., … Shaw, P. C. (2008). Structure of the influenza virus A H5N1 nucleoprotein: Implications for RNA binding, oligomerization, and vaccine design. The FASEB Journal, 22, 3638–3647.10.1096/fj.08-112110
   PubMed Web of Science ®Google Scholar
• Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., … Schulten, K. (2005). Scalable molecular dynamics with NAMD. Journal of Computational Chemistry, 26, 1781–1802.10.1002/(ISSN)1096-987X
   PubMed Web of Science ®Google Scholar
• Purohit, R. (2014). Role of ELA region in auto-activation of mutant KIT receptor: A molecular dynamics simulation insight. Journal of Biomolecular Structure & Dynamics, 32, 1033–1046.
   PubMed Web of Science ®Google Scholar
• Purohit, R., Rajendran, V., & Sethumadhavan, R. (2011a). Relationship between mutation of serine residue at 315th position in M. tuberculosis catalase-peroxidase enzyme and isoniazid susceptibility: An in silico analysis. Journal of Molecular Modeling, 17, 869–877.10.1007/s00894-010-0785-6
   PubMed Web of Science ®Google Scholar
• Purohit, R., Rajendran, V., & Sethumadhavan, R. (2011b). Studies on adaptability of binding residues and flap region of TMC-114 resistance HIV-1 protease mutants. Journal of Biomolecular Structure & Dynamics, 29, 137–152.
   PubMed Web of Science ®Google Scholar
• Rajendran, V., Purohit, R., & Sethumadhavan, R. (2012). In silico investigation of molecular mechanism of laminopathy caused by a point mutation (R482W) in lamin A/C protein. Amino Acids, 43, 603–615.10.1007/s00726-011-1108-7
   PubMed Web of Science ®Google Scholar
• Rajendran, V., & Sethumadhavan, R. (2014). Drug resistance mechanism of PncA in Mycobacterium tuberculosis. Journal of Biomolecular Structure & Dynamics, 32, 209–221.
   PubMed Web of Science ®Google Scholar
• Reguera, J., Malet, H., Weber, F., & Cusack, S. (2013). Structural basis for encapsidation of genomic RNA by La crosse orthobunyavirus nucleoprotein. Proceedings of the National Academy of Sciences, 110, 7246–7251.10.1073/pnas.1302298110
   PubMed Web of Science ®Google Scholar
• Ruigrok, R. W., Crépin, T., & Kolakofsky, D. (2011). Nucleoproteins and nucleocapsids of negative-strand RNA viruses. Current Opinion in Microbiology, 14, 504–510.10.1016/j.mib.2011.07.011
   PubMed Web of Science ®Google Scholar
• Sharma, M., & Ray, S. M. (2008). Synthesis and biological evaluation of amide derivatives of (5,6-dimethoxy-2,3-dihydro-1H-inden-1-yl) acetic acid as anti-inflammatory agents with reduced gastrointestinal ulcerogenecity. European Journal of Medicinal Chemistry, 43, 2092–2102.10.1016/j.ejmech.2007.08.008
   PubMed Web of Science ®Google Scholar
• Shen, Y. F., Chen, Y. H., Chu, S. Y., Lin, M. I., Hsu, H. T., Wu, P. Y., … Tsai, M. D. (2011). E339 … R416 salt bridge of nucleoprotein as a feasible target for influenza virus inhibitors. Proceedings of the National Academy of Sciences, 108, 16515–16520.10.1073/pnas.1113107108
   PubMed Web of Science ®Google Scholar
• Shih, S. R., Horng, J. T., Poon, L. L., Chen, T. C., Yeh, J. Y., Hsieh, H. P., … Hsu, J. T. (2010). BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses. Journal of Antimicrobial Chemotherapy, 65, 63–71.10.1093/jac/dkp393
   PubMed Web of Science ®Google Scholar
• Slama Schwok, A., Delmas, B., Quideau, S., Bertrand, H., & Tarus, B. (2012). Antiviral compositions directed against the influenza virus nucleoprotein. International patent extension no PCT/EP2012/001720 deposited April 21, 2012.
   Google Scholar
• Sulyok, G. A., Gibson, C., Goodman, S. L., Hölzemann, G., Wiesner, M., & Kessler, H. (2001). Solid-phase synthesis of a nonpeptide RGD mimetic library: New selective alphavbeta3 integrin antagonists. Journal of Medicinal Chemistry, 44, 1938–1950.10.1021/jm0004953
   PubMed Web of Science ®Google Scholar
• Tarus, B., Bakowiez, O., Chenavas, S., Duchemin, L., Estrozi, L. F., Bourdieu, C., … Slama-Schwok, A. (2012). Oligomerization paths of the nucleoprotein of influenza A virus. Biochimie, 94, 776–785.10.1016/j.biochi.2011.11.009
   PubMed Web of Science ®Google Scholar
• Tarus, B., Chevalier, C., Richard, C. A., Delmas, B., Di Primo, C., & Slama-Schwok, A. (2012). Molecular dynamics studies of the nucleoprotein of influenza A virus: Role of the protein flexibility in RNA binding. PLoS ONE, 7, e30038.10.1371/journal.pone.0030038
   PubMedGoogle Scholar
• Tawar, R. G., Duquerroy, S., Vonrhein, C., Varela, P. F., Damier-Piolle, L., Castagne, N., … Rey, F. A. (2009). Crystal structure of a nucleocapsid-like nucleoprotein-RNA complex of respiratory syncytial virus. Science, 326, 1279–1283.10.1126/science.1177634
   PubMed Web of Science ®Google Scholar
• Wang, J., Ma, C., Fiorin, G., Carnevale, V., Wang, T., Hu, F., … DeGrado, W. F. (2011). Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2. Journal of the American Chemical Society, 133, 12834–12841.10.1021/ja204969m
   PubMed Web of Science ®Google Scholar
• Ye, Q., Guu, T. S., Mata, D. A., Kuo, R. L., Smith, B., Krug, R. M., & Tao, Y. J. (2012). Biochemical and structural evidence in support of a coherent model for the formation of the double-helical influenza A virus ribonucleoprotein. MBio, 4, e00467–00412.
   Web of Science ®Google Scholar
• Ye, Q., Krug, R. M., & Tao, Y. J. (2006). The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. Nature, 444, 1078–1082.10.1038/nature05379
   PubMed Web of Science ®Google Scholar